Madison, Wis. The National Lung Cancer Partnership announced today they are joining three distinguished organizations: the Lance Armstrong Foundation, the Oncology Nursing Society Foundation and the International Association for the Study of Lung Cancer in continuing the mission to increase opportunities for lung cancer researchers by co-sponsoring new lung cancer research grants.
Lung cancer is the leading cancer killer of men and women in the United States but it receives less research funding than almost any other cancer.
If we are going to conquer this disease we need to bring new researchers and specialized professionals like oncology nurses into the field, said Joan Schiller, M.D., president of the National Lung Cancer Partnership, deputy director of Simmons Comprehensive Cancer Center and division director of Hematology/Oncology at the University of Texas-Southwestern Medical Center, Dallas. At the same time, we need to add to research that will help us identify best practices when it comes to helping survivors live better lives.
The Lance Armstrong Foundation and the National Lung Cancer Partnership will co-sponsor a Young Investigator survivorship grant, which will fund lung cancer survivorship research projects, such as an investigation of access to quality survivor care and services for lung cancer survivors.
National Lung Cancer Partnership and the Oncology Nursing Society Foundation are co-sponsoring the Lung Cancer Nursing Research Grant, which will support research addressing lung cancer and focusing on areas that will advance the science and practice of oncology nursing, such as research into nursing-sensitive patient outcomes.
The third new grant in conjunction with the International Association of the Study of Lung Cancer (IASLC), will provide research funding for the training of young investigators interested in lung cancer research as well as require recipients to take one course per year within their doctoral program in an area that the candidate has not received prior training, such as biostatistics, epidemiology or clinical trials.
Funding for lung cancer research is hard to come by, and this creates an enormous obstacle to researchers in all specialties, said Regina Vidaver, executive director of the National Lung Cancer Partnership. By removing that obstacle for some researchers we are supporting progress toward better treatments and someday a cure.
|Contact: Sara Conley|
National Lung Cancer Partnership